Discovery of <i>N</i>‑(1,3,4-Thiadiazol-2-yl)amide Derivatives as Uncompetitive Inhibitors of 6‑Phosphogluconate Dehydrogenase by Rong Zhang (44942)

“…Among them, <b>19n</b> exhibited significant potency against 6PGD with an IC₅₀ value of 5.1 ± 1.0 μM. …”

TAD boundary stability for different noise amplitudes for all chromosomes. by Lucas Hedström (21688891)

Charge Delocalization for Electrically Detachable Poly(ionic liquids) Ionoadhesives with Ultrahigh Mechanical Robustness by Shijie Sun (9385097)

“…In addition, charge delocalization sharply decreases the escaping energy of mobile ions and thus significantly facilitates ion hopping. …”

Charge Delocalization for Electrically Detachable Poly(ionic liquids) Ionoadhesives with Ultrahigh Mechanical Robustness by Shijie Sun (9385097)

“…In addition, charge delocalization sharply decreases the escaping energy of mobile ions and thus significantly facilitates ion hopping. …”

Charge Delocalization for Electrically Detachable Poly(ionic liquids) Ionoadhesives with Ultrahigh Mechanical Robustness by Shijie Sun (9385097)

“…In addition, charge delocalization sharply decreases the escaping energy of mobile ions and thus significantly facilitates ion hopping. …”

Charge Delocalization for Electrically Detachable Poly(ionic liquids) Ionoadhesives with Ultrahigh Mechanical Robustness by Shijie Sun (9385097)

“…In addition, charge delocalization sharply decreases the escaping energy of mobile ions and thus significantly facilitates ion hopping. …”

Predicted behavioural expression of young (orange) and old (blue) individuals that do (treatment) or do not (control) receive an immune challenge. by Antoine Bour (20489426)

“…<p>(a) If an immune challenge causes sickness behaviour then we expect that young and old immune-challenged individuals will decrease their population-level average behavioural expression compared with controls with old individuals decreasing their behavioural expression more than young individuals. …”

Source data file. by Laura Mora-Bitria (20477525)

“…Our results were validated in an independent data set. We conclude that iKIRs significantly decrease HLA class II protective associations and suggest that iKIRs regulate CD4⁺ T cell responses in T1D.…”

Supporting data file. by Laura Mora-Bitria (20477525)

“…Our results were validated in an independent data set. We conclude that iKIRs significantly decrease HLA class II protective associations and suggest that iKIRs regulate CD4⁺ T cell responses in T1D.…”

Renal outcomes of both treatment groups. by Marwan El-Deyarbi (21688492)

“…</p><p>Conclusions</p><p>Implementing multifactorial interventions by a multidisciplinary team improved several clinical manifestations, including HbA1c, SBP, and eGFR, and decreased cardiovascular risk factors despite the decreased diabetes medication use.…”

Demographics by Country and Gender. by Deeviya Francis Xavier (21485043)

“…Regarding creative self-efficacy, we found gender-specific impacts, with male participants experiencing a decrease, contrary to our expectations. …”

Study Data. by Deeviya Francis Xavier (21485043)

“…Regarding creative self-efficacy, we found gender-specific impacts, with male participants experiencing a decrease, contrary to our expectations. …”

Ablation results. by Gang Xu (219455)

“…To address this limitation, we propose a novel network framework called ImVoxelGNet. …”

Complexity comparison results. by Gang Xu (219455)

“…To address this limitation, we propose a novel network framework called ImVoxelGNet. …”

Ablation results on Nerf-Det [28]. by Gang Xu (219455)

“…To address this limitation, we propose a novel network framework called ImVoxelGNet. …”

Ablation results on noise. by Gang Xu (219455)

“…To address this limitation, we propose a novel network framework called ImVoxelGNet. …”

Overview of annotated metabolites. by Yunfei Xu (3156420)

“…<div><p>Tea ranks among the top three most beloved non-alcoholic beverages worldwide and boasts significant economic and health benefits. In addition to <i>Camellia sinensis</i> (L.) …”

Baseline analysis, nominal factors. by Hiroaki Yoshikawa (4615801)

“…Regarding treatment, the utilization of tacrolimus, plasma exchange (PE), and intravenous immunoglobulin (IVIg) significantly increased between 2006 and 2018. In contrast, the rates of thymectomy and both maximum and current oral steroid dosages decreased during this period.…”

Minimal dataset for the study. by Hiroaki Yoshikawa (4615801)

“…Regarding treatment, the utilization of tacrolimus, plasma exchange (PE), and intravenous immunoglobulin (IVIg) significantly increased between 2006 and 2018. In contrast, the rates of thymectomy and both maximum and current oral steroid dosages decreased during this period.…”

Baseline analysis, continuous factors. by Hiroaki Yoshikawa (4615801)

“…Regarding treatment, the utilization of tacrolimus, plasma exchange (PE), and intravenous immunoglobulin (IVIg) significantly increased between 2006 and 2018. In contrast, the rates of thymectomy and both maximum and current oral steroid dosages decreased during this period.…”